Live Breaking News & Updates on Clinical research centres

Stay informed with the latest breaking news from Clinical research centres on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Clinical research centres and stay connected to the pulse of your community

HUL funds 1st of its kind top academia-led holistic research in India

HUL funds 1st of its kind top academia-led holistic research in India
adgully.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adgully.com Daily Mail and Mail on Sunday newspapers.

Hindustan , India-general- , India , Bangalore , Karnataka , Vellore , Tamil-nadu , Pune , Maharashtra , Sanjiv-mehta , Hindustan-unilever , Indian-network

MOH starts Ivermectin trial for high risk Covid-19 patients

06 Jun 2021 / 07:14 H.
KUALA LUMPUR: The Ministry of Health (MOH) and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 MOH’s hospitals.
Health director-general Tan Sri Dr Noor Hisham Abdullah
(pix) said Ivermectin is a Food and Drug Administration (FDA) approved antiparasitic drug widely used for treating several neglected tropical diseases, including onchocerciasis, strongyloidiasis and helminthiases, however, the evidence is inconclusive to recommend routine use of Ivermectin for Covid-19 patients.
“The ‘off-label’ use of Ivermectin gained global attention due to some promising results by case studies and clinical trials.

Ipoh , Perak , Malaysia , Kuala-lumpur , Malaysian , Noor-hisham , Raja-permaisuri-bainun , Noor-hisham-abdullah , Institute-for-clinical-research , Ministry-of-health , Drug-administration , National-pharmaceutical-regulatory-agency

Malaysia starts Ivermectin trial for high risk COVID-19 patients

Malaysia starts Ivermectin trial for high risk COVID-19 patients
outbreaknewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outbreaknewstoday.com Daily Mail and Mail on Sunday newspapers.

Ipoh , Perak , Malaysia , Malaysian , Raja-permaisuri-bainun , Institute-for-clinical-research , Ministry-of-health-malaysia , World-health-organization , Ethics-committee , National-pharmaceutical-regulatory-agency , Clinical-research-centres , Randomised-evaluation

Dr Noor Hisham: Health Ministry has begun Ivermectin trial for high-risk Covid-19 patients

KUALA LUMPUR (Bernama): The Health Ministry and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 of the ministry's hospitals.

Ipoh , Perak , Malaysia , Kuala-lumpur , Malaysian , Noor-hisham , Raja-permaisuri-bainun , Noor-hisham-abdullah , Institute-for-clinical-research , Drug-administration , National-pharmaceutical-regulatory-agency , Ethics-committee-on

Dr Noor Hisham: Health Ministry starts Ivermectin trial for high-risk Covid-19 patients | Malaysia

KUALA LUMPUR, June 5 — The Ministry of Health (MOH) and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 MOH’s hospitals. Health director-general Tan Sri Dr Noor Hisham Abdullah said...

Ipoh , Perak , Malaysia , Kuala-lumpur , Malaysian , Noor-hisham , Hari-anggara , Raja-permaisuri-bainun , Noor-hisham-abdullah , Instagram , Institute-for-clinical-research , Ministry-of-health

Phase 3 clinical trial on Jan 21 | Daily Express Online - Sabah's Leading News Portal

Published on: Tuesday, January 12, 2021
By: Bernama
Text Size:
Kuala Lumpur: A phase 3 Covid-19 vaccine clinical trial will start on Jan 21 at nine Health Ministry (MOH) hospitals by their respective Clinical Research Centres (CRC), said Prime Minister Tan Sri Muhyiddin Yassin
(pic).
In announcing the matter, he said the first clinical trial conducted in Malaysia was expected to involve 3,000 volunteers.
“Malaysia will be the first country outside China to conduct the trial of inactivated Covid-19 vaccine candidate made by the Institute of Medical Biology Chinese Academy of Medical Sciences, China (IMBCAMS).
ADVERTISEMENT
“All regulatory requirements including ethical approval from the Medical Review & Ethics Committee (MREC) and finally, the Clinical Trial Import License (CTIL) from NPRA were obtained on January 8, 2021,” he said in a special address broadcast live on local television stations, Monday.

China , Kuala-lumpur , Malaysia , Malaysian , Chinese , Muhyiddin-yassin , Immunisation-programme-plan , National-pharmaceutical-regulatory-agency , Health-ministry , Clinical-research-centres , Pfizer , Astrazeneca